Medxy AI

Diabetes & Endocrinology news Pathology & Lab Medicine/Bệnh học

Enzymatic 2-Hydroxybutyrate Assay: A Novel Screening Tool to Detect Dysglycemia Beyond Standard Fasting Tests

By MedXY 08/13/2026

A novel enzymatic assay measuring fasting 2-hydroxybutyrate shows high accuracy in identifying postprandial dysglycemia in individuals with normal fasting glucose and HbA1c, offering an improved screening approach for early glucose metabolism abnormalities.

Cardiology news OB/GYN & Women’s Health

Progress and Prognostic Insights in Fetal Cardiomyopathy: Findings from a Multicenter North American Cohort

By MedXY 08/13/2026

This multicenter study reveals improved outcomes in fetal cardiomyopathy, highlights genetic underpinnings in one-third of cases, and identifies fetal hydrops and extracardiac anomalies as key prenatal risk factors for mortality.

Cardiology Clinical Updates news Radiology

Vutrisiran Treatment and Cardiovascular MRI-Detected Changes in Cardiac Structure, Function, and Amyloid Burden in ATTR-CM

By MedXY 08/13/2026

Vutrisiran, an RNA interference therapeutic, significantly improves cardiac function, reduces amyloid burden, and attenuates disease progression in transthyretin amyloid cardiomyopathy as revealed by multiparametric cardiovascular MRI and corroborated by echocardiographic findings.

Cardiology news Public Health

Beyond BMI: How Waist Circumference and Waist-to-Hip Ratio Enhance Cardiovascular Risk Prediction

By MedXY 08/13/2026

This analysis reveals that waist circumference and waist-to-hip ratio improve cardiovascular risk classification beyond BMI, identifying individuals with hidden risk and refining prognostic assessments across multiple cardiovascular outcomes.

Neurology news Pathology & Lab Medicine/Bệnh học

Evaluating Antibody Detection Methods in Myasthenia Gravis: Insights from the ADAM Study

By MedXY 08/13/2026

The ADAM Study demonstrates superior diagnostic accuracy of live cell-based assays over fixed cell-based and ELISA tests for detecting AChR antibodies in myasthenia gravis, highlighting important clinical implications for antibody testing strategies.

Gastroenterology news

Validating Liver Stiffness Measurement as a Prognostic Tool in Primary Sclerosing Cholangitis: Insights from the Prospective FICUS Cohort

By MedXY 08/13/2026

This prospective study confirms that liver stiffness measurement (LSM) by Fibroscan® effectively predicts transplant-free survival in primary sclerosing cholangitis (PSC), highlighting both static and dynamic assessments as powerful risk stratification and potential clinical trial endpoints.

Dermatology news Oncology

Long-Term Survival Benefit of Spartalizumab with Dabrafenib and Trametinib in BRAF V600-Mutant Advanced Melanoma: Insights from the COMBI-I Trial

By MedXY 08/13/2026

The COMBI-I trial demonstrates that adding spartalizumab to dabrafenib and trametinib improves overall survival in patients with BRAF V600-mutant advanced melanoma after over 6 years of follow-up, despite not meeting the initial progression-free survival endpoint.

Cardiology Nephrology news

Pre-Transplant Left Atrial Volume Index as a Predictor of One-Year Morbidity after Kidney Transplantation: Insights and Implications

By MedXY 08/12/2026

This study identifies pre-transplant left atrial volume index as a potential predictor for overall one-year morbidity following kidney transplantation, highlighting its clinical relevance beyond traditional cardiac risk markers.

Diabetes & Endocrinology General Surgery news

Normothermic Regional Perfusion: A Paradigm Shift in Pancreas and Islet Transplantation from DCD Donors

By MedXY 08/12/2026

Normothermic regional perfusion (NRP) offers a promising approach to reduce ischemic injury in pancreas and islet transplantation using donation after circulatory death (DCD) donors, improving graft quality and expanding donor availability.

Dermatology news

A Practical Framework for Pyoderma Gangrenosum: Expert Consensus Defines Phenotypes and Modifiers

By MedXY 08/12/2026

An expert Delphi panel established a standardized, descriptive classification for pyoderma gangrenosum (PG) to improve diagnosis, research, and treatment planning by defining distinct phenotypes and key disease modifiers.

Allergy & Immunology Dermatology news

Early Prediction of Dupilumab Efficacy in Facial Atopic Dermatitis via Reflectance Confocal Microscopy and Deep Learning

By MedXY 08/12/2026

Reflectance confocal microscopy features at week 4 post-dupilumab treatment, combined with deep learning analysis, enable non-invasive prediction of therapeutic response in facial atopic dermatitis patients.

news OB/GYN & Women's Health Plastic Surgery

Optimizing Breast Augmentation Through Tissue Preservation and 3D Geometric Analysis: Clinical Insights and Outcomes

By MedXY 08/12/2026

A retrospective study validates tissue-preserving breast augmentation using 3D imaging and ultrasound, demonstrating enhanced stability, natural aesthetics, and low complication rates.

news Plastic Surgery

Optimizing Botulinum Toxin Injections for Oral Commissure Elevation: Insights from a Rigorous Two-Stage Randomized Trial

By MedXY 08/12/2026

A prospective, double-blind study demonstrates that lower depressor anguli oris (DAO) injections of botulinum toxin type A, especially combined with platysma (PLT) injections, effectively elevate oral commissures with high patient satisfaction and minimal side effects.

Neurology news Psychiatry

Unraveling the Neurobiological Pathways Linking Childhood Trauma to Bipolar Disorder: Insights from the ENIGMA Consortium

By MedXY 08/12/2026

An international study reveals that childhood trauma’s association with bipolar disorder is partially mediated by brain morphology changes, particularly in hippocampal volume and frontal cortical thickness.

Critical Care Internal Medicine news

Ultra-Early Versus Early Vasopressin Initiation After Norepinephrine Escalation in Septic Shock: Insights from a Target Trial Emulation

By MedXY 08/12/2026

This study emulated a target trial to compare ultra-early (0-3h) versus early (>3-6h) vasopressin initiation after norepinephrine escalation in septic shock, revealing significant mortality and renal therapy benefits with ultra-early use.

Critical Care Nephrology news

Unraveling the Complex Benefits and Risks of Renal Replacement Therapy in ICU Patients: Insights from a Japanese Registry

By MedXY 08/12/2026

This study highlights varied outcomes of renal replacement therapy in critically ill patients, identifying subgroups who may benefit despite an overall increase in mortality risk.

Diabetes & Endocrinology Internal Medicine news

Empowering Internal Medicine Residents to Combat Obesity: A Comprehensive Training Pathway in an Underserved Urban Clinic

By MedXY 08/12/2026

A novel longitudinal obesity medicine training pathway for internal medicine residents, implemented at an urban Federally Qualified Health Center, improves physician confidence and management skills in obesity care, preparing trainees for board certification and addressing unmet educational needs.

Clinical Updates news Oncology Respiratory

Enhancing Lung Cancer Screening Adherence: Insights from a Randomized Clinical Trial of Health Communication and Stepped Reminder Interventions

By MedXY 08/12/2026

A landmark randomized trial demonstrates that multilevel stepped reminders targeting both primary care physicians and patients markedly improve adherence to annual lung cancer screening, while health communication alone may be insufficient or counterproductive.

news Orthopedics

Surgical Arthrodesis Versus Watchful Waiting in Hallux Rigidus: Insights from a Landmark Randomized Controlled Trial

By MedXY 08/12/2026

First MTPJ arthrodesis significantly reduces walking pain at 12 months in hallux rigidus patients compared with watchful waiting, demonstrating a clinically meaningful benefit in this common foot osteoarthritis.

Hematology-Oncology news

Real-World Incidence, Risk Factors, and Biomarker Validation for SOS/VOD After Allogeneic HSCT in Adults: Insights from the Spanish GETH-TC Registry

By MedXY 08/12/2026

A comprehensive retrospective analysis of 793 adult allo-HSCT cases identifies key clinical risk factors and validates the EASIX score as a predictive biomarker for SOS/VOD, highlighting the syndrome's significant impact on non-relapse mortality.